Abstract:Vancomycin is a renally excreted drug, and its body clearance correlates with creatinine clearance. However, the renal function estimation equation that best predicts vancomycin clearance has not been established yet. The objective of this study was to compare the abilities of different renal function estimation equations to describe vancomycin pharmacokinetics in elderly patients. The NPAG algorithm was used to perform population pharmacokinetic analysis of vancomycin concentrations in 78 elderly patients. Si… Show more
“…Our group has investigated this question in elderly patients for two antimicrobials, gentamicin, and vancomycin, using a population pharmacokinetic approach. For gentamicin, the CG equation better predicted the drug clearance than the MDRD equation , while for vancomycin, the results were comparable except for CKD‐EPI which performed worst . These results and others suggest that a good marker of the GFR is not necessarily a good marker of drug clearance.…”
The objectives of this study were to compare the estimations of renal function obtained with six equations, including the Cockcroft-Gault (CG), Modification of Diet in Renal Disease (MDRD), and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations and to evaluate the implication of using other equations for drug dosing in elderly patients in place of CG. An observational prospective study was conducted over 6 months in two geriatric hospitals with inclusions of all hospitalized inpatients. A list of 36 drugs for which recommendations of dosage adjustment for renal function were mentioned in the manufacturer dosing guidelines was used to compare the implications of using the various equations for drug dosing. A total of 249 patients with a mean age of 83.6 years were included. Mean estimates of renal function from the CG, MDRD, and CKD-EPI equations were 51.3 ± 23.5 mL/min, 72.2 ± 35.2, and 64.3 ± 22.5 mL/min/1.73 m , respectively (P < 0.001). Twenty percent of patients had at least one drug for which the dose was not appropriately adjusted to renal function. The use of the MDRD and CKD-EPI equations in place of the CG equation was associated with dosage discrepancy in 20-25% of patients and 15% of drug orders, resulting in potential overdosage in 95% of cases. Use of MDRD or CKD-EPI equations results in higher estimates of renal function and may have important implications for drug dosing decision and drug safety in elderly patients. The best way is to directly measure the drug effect or its concentration when it is possible to do so.
“…Our group has investigated this question in elderly patients for two antimicrobials, gentamicin, and vancomycin, using a population pharmacokinetic approach. For gentamicin, the CG equation better predicted the drug clearance than the MDRD equation , while for vancomycin, the results were comparable except for CKD‐EPI which performed worst . These results and others suggest that a good marker of the GFR is not necessarily a good marker of drug clearance.…”
The objectives of this study were to compare the estimations of renal function obtained with six equations, including the Cockcroft-Gault (CG), Modification of Diet in Renal Disease (MDRD), and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations and to evaluate the implication of using other equations for drug dosing in elderly patients in place of CG. An observational prospective study was conducted over 6 months in two geriatric hospitals with inclusions of all hospitalized inpatients. A list of 36 drugs for which recommendations of dosage adjustment for renal function were mentioned in the manufacturer dosing guidelines was used to compare the implications of using the various equations for drug dosing. A total of 249 patients with a mean age of 83.6 years were included. Mean estimates of renal function from the CG, MDRD, and CKD-EPI equations were 51.3 ± 23.5 mL/min, 72.2 ± 35.2, and 64.3 ± 22.5 mL/min/1.73 m , respectively (P < 0.001). Twenty percent of patients had at least one drug for which the dose was not appropriately adjusted to renal function. The use of the MDRD and CKD-EPI equations in place of the CG equation was associated with dosage discrepancy in 20-25% of patients and 15% of drug orders, resulting in potential overdosage in 95% of cases. Use of MDRD or CKD-EPI equations results in higher estimates of renal function and may have important implications for drug dosing decision and drug safety in elderly patients. The best way is to directly measure the drug effect or its concentration when it is possible to do so.
“…SCRs <0.5 mg/dL were set to 0.5 mg/dL to avoid potential bias from an overestimation of renal function and to provide better estimates of vancomycin clearance in patients with low creatinine production . The MDRD and CKD‐EPI equations were adjusted to individual BSA values (GFR = (MDRD or CKD‐EPI) × (BSA/1.73)) to reduce the bias for population prediction . Number of patients with unstable renal function was determined when the eGFR, estimated using the CKD‐EPI equation, decreased by 30 mL/min from the previous or baseline eGFR data.…”
Section: Methodsmentioning
confidence: 99%
“…The use of a renal function estimation equation different from that used in model building could significantly alter the predictive performance for vancomycin PK . The performance of the same population PK model should be compared across various renal function estimation methods to consider the interchangeability of renal function estimation methods in population PK modelling.…”
What is known and objective
Although patients may have received vancomycin therapy with therapeutic drug monitoring (TDM), those treated with high‐strength and long‐term vancomycin therapy might have unstable and time‐varying renal function. The methods used to estimate renal function should not be considered interchangeable with pharmacokinetic (PK) modeling and model‐based estimation of vancomycin pharmacokinetics. While Chronic Kidney Disease Epidemiology Collaboration (CKD‐EPI) for renal function estimation has been widely integrated into clinical practice, a population PK model including CKD‐EPI has not been established. The study was aimed at developing a new population PK model for optimal vancomycin prediction in patients with time‐varying and variable renal function to evaluate the interchangeability of estimation methods.
Methods
The most suitable population PK model was explored and evaluated using non‐linear mixed‐effect modelling for the best fit of vancomycin concentrations from patients who needed to maintain high trough vancomycin concentrations of >10 mg/L or >15 mg/L. Renal function was estimated using the Cockcroft‐Gault (CG), Modification of Diet in Renal Disease (MDRD) and CKD‐EPI equations. NONMEM 7.4 was used to develop the population PK model.
Results
A total of 328 vancomycin concentrations in 99 patients were used to develop the population PK model. Vancomycin pharmacokinetics was best described by a two‐compartment model. The CKD‐EPI equation for vancomycin clearance was included in the final model among the estimation methods of renal function. A new covariate model, including extended covariate parameters that explain changes in renal function from the population‐predicted value and individual dosing time, provided the best explanation for vancomycin pharmacokinetics among the various models tested.
What is new and conclusion
A new extended covariate model for vancomycin using the CKD‐EPI method may afford suitable dose adjustment for high‐strength and long‐term vancomycin therapy that results in unstable renal function.
“…Conversely, a study by Tsuji et al found that if the serum creatinine is measured using the Jaffe method, instead of the IDMS method, then a correction of serum creatinine to 0.68 mg/dL is unnecessary within the CG equation [56]. Additionally, a study by Glatard et al found that the CG equation, MDRD equation, and CKD-EPI equations are not interchangeable when calculating vancomycin dosing and prediction of concentrations based on renal function [57]. The authors concluded that whichever equation clinicians utilize to calculate renal function should be the same equation used to dose renally eliminated drugs.…”
Section: Key Clinical Issuesmentioning
confidence: 99%
“…As vancomycin is approximately 90% renally eliminated unchanged in the urine [56, 57], it is imperative to accurately estimate renal function when calculating dosing regimens to help optimize the pharmacokinetic and pharmacodynamic properties of the drug. Cutler et al compared vancomycin kinetics in younger patients (mean age: 23 years) versus older patients (mean age: 68 years) [58].…”
The elderly population can be divided into three distinct age groups: 65–74 years (young-old), 75–84 years (middle-old), and 85+ years (old-old). Despite evidence of a shift in leading causes for mortality in the elderly from infectious diseases to chronic conditions, infections are still a serious cause of death in this population. These patients are at increased risk due to weakened immune systems, an increased prevalence of underlying comorbidities, and decreased physiologic reserves to fight infection. Additionally, elderly patients, especially adults in institutional settings, are at an increased risk of colonization and subsequent infection with methicillin-resistant Staphylococcus aureus at a rate that is five times higher than in younger individuals, causing an increase in empiric and definitive vancomycin use. Elderly patients have unique characteristics that make dosing vancomycin a challenge for clinicians, such as increased volume of distribution and decreased renal function. Using the best available evidence, it is recommended to initiate lower empiric maintenance doses and monitor vancomycin serum concentrations earlier than steady state to accurately calculate drug elimination and make appropriate dose adjustments.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.